' 
![]()
SCIENTIFIC SCORE
Moderately Effective
Based on 40 Researches
8
USERS' SCORE
Good
Based on 3 Reviews
8.5
Supplement Facts
Serving Size: 2 Capsules
Amount Per Serving
%DV
Proprietary Probiotic BlendLacticaseibacillus rhamnosus R0011Lactobacillus helvetius R0052Pediococcus acidilactici R1001Lacticaseibacillus casei R0215Bifidobacterium longum BB536Lactiplantibacillus plantarum R1012Bifidobacterium breve R0070Lactococcus lactis subsp. lactis R1058
131 mg (10 Billion CFU)
†
Top Medical Research Studies
8
Bifidobacterium longum shows potential benefits
Bifidobacterium longum subsp. longum XZ01 delays the progression of colon cancer in mice through the interaction between the microbial spatial distribution and tumour immunity.
Moderate relevance to cancer therapy
We investigated whether Bifidobacterium longum XZ01 could affect the progression of colon cancer in a mouse model. The results hinted that this probiotic might enhance immune responses by outcompeting harmful bacteria and protecting macrophages within tumors.
Notably, XZ01 appears to foster a favorable tumor immune environment, promoting immune cell activation while inhibiting certain immune suppression. By interacting with microbial communities, this treatment shows promise for potentially improving colon cancer immunotherapy strategies.
More research is necessary to confirm these effects in humans, but these findings open doors to innovative cancer treatments.
Notably, XZ01 appears to foster a favorable tumor immune environment, promoting immune cell activation while inhibiting certain immune suppression. By interacting with microbial communities, this treatment shows promise for potentially improving colon cancer immunotherapy strategies.
More research is necessary to confirm these effects in humans, but these findings open doors to innovative cancer treatments.
Read More
9
Bifidobacterium longum inhibits cancer growth
Cell free supernatants of Bifidobacterium adolescentis and Bifidobacterium longum suppress the tumor growth in colorectal cancer organoid model.
High relevance to cancer research
We explored the effects of probiotic bacteria and their metabolites on colorectal cancer (CRC) growth through a study comparing CRC patients with healthy individuals.
Our findings revealed that beneficial strains like Bifidobacterium longum were significantly less prevalent in CRC patients. We treated cancer organoid lines with metabolites from various bacteria, including Bifidobacterium longum, and observed a notable reduction in cancer growth.
This research emphasizes how the loss of beneficial bacteria and their metabolites could contribute to cancer development and showcases the potential of these metabolites in inhibiting CRC growth.
Our findings revealed that beneficial strains like Bifidobacterium longum were significantly less prevalent in CRC patients. We treated cancer organoid lines with metabolites from various bacteria, including Bifidobacterium longum, and observed a notable reduction in cancer growth.
This research emphasizes how the loss of beneficial bacteria and their metabolites could contribute to cancer development and showcases the potential of these metabolites in inhibiting CRC growth.
Read More
9
B. longum enhances liver recovery
Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma.
Significant relevance to cancer recovery
We explored how timely liver function recovery (LFR) impacts long-term survival in hepatocellular carcinoma (HCC) patients and discovered Bifidobacterium longum, which is linked to improved recovery. In our study, we found that transferring fecal microbiota from HCC patients with delayed recovery to mice affected their recovery. Remarkably, giving these mice B. longum sped up their liver repair. In a clinical trial, a probiotic cocktail with B. longum significantly lowered recovery delays and shortened hospital stays for HCC patients, ultimately boosting their one-year survival rates.
Read More
Most Useful Reviews
8.8
Improved intestinal health
I am pleasantly surprised. After taking 2 or 3 tablets daily for ten days, I noticed positive changes. My usual morning stool now comes out around 2 pm. Previously, I experienced painful bloating after lunch, but that discomfort has disappeared, and my bowel movements are much smoother. After my mother died of colon cancer, I feared inheriting that issue, so I started this to improve my gut health. I look forward to continuing this and hope it will benefit both my intestinal and skin health over the next three months.
Read More
8.5
Effective against constipation
I had high hopes for this probiotic after experiencing cancer previously. It effectively alleviates my severe constipation, and I noticed positive results within five years, even with just one a day. I will definitely repurchase!
Read More
8
Positive response noted
Good effects of lactic acid bacteria. After taking it two hours post-meal, my constipation improved, which is a welcomed relief. I also heard that maintaining bowel health may reduce the recurrence of cancer.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 40 Researches
8
9
Probiotic-based cancer treatment strategy
Anaerobic probiotics-in situ Se nanoradiosensitizers selectively anchor to tumor with immuno-regulations for robust cancer radio-immunotherapy.
High relevance to cancer therapies
We explored how a novel approach using bifidobacterium longum combined with selenium nanoparticles might improve cancer treatment. This method targets tumor cells in oxygen-poor environments to halt their growth, while simultaneously boosting the immune response against cancer.
The therapy not only damages tumor cells but also reduces the number of immunosuppressive cells in tumors. However, there is no significant mention of direct benefits in long-term cancer outcomes. This innovative strategy aims to enhance the efficacy of traditional radiotherapy, offering a promising avenue for future treatments.
The therapy not only damages tumor cells but also reduces the number of immunosuppressive cells in tumors. However, there is no significant mention of direct benefits in long-term cancer outcomes. This innovative strategy aims to enhance the efficacy of traditional radiotherapy, offering a promising avenue for future treatments.
Read More
9
Bifidobacterium longum inhibits cancer growth
Cell free supernatants of Bifidobacterium adolescentis and Bifidobacterium longum suppress the tumor growth in colorectal cancer organoid model.
High relevance to cancer research
We explored the effects of probiotic bacteria and their metabolites on colorectal cancer (CRC) growth through a study comparing CRC patients with healthy individuals.
Our findings revealed that beneficial strains like Bifidobacterium longum were significantly less prevalent in CRC patients. We treated cancer organoid lines with metabolites from various bacteria, including Bifidobacterium longum, and observed a notable reduction in cancer growth.
This research emphasizes how the loss of beneficial bacteria and their metabolites could contribute to cancer development and showcases the potential of these metabolites in inhibiting CRC growth.
Our findings revealed that beneficial strains like Bifidobacterium longum were significantly less prevalent in CRC patients. We treated cancer organoid lines with metabolites from various bacteria, including Bifidobacterium longum, and observed a notable reduction in cancer growth.
This research emphasizes how the loss of beneficial bacteria and their metabolites could contribute to cancer development and showcases the potential of these metabolites in inhibiting CRC growth.
Read More
9
Probiotics may enhance immunotherapy
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice.
Significant effect on treatment efficacy
We investigated how Bifidobacterium longum, alongside Bifidobacterium infantis, might enhance the effectiveness of cancer immunotherapy. In a mouse study, these probiotics were administered alongside an antibiotic known to undermine the action of cancer treatments.
Surprisingly, while the antibiotic alone led to increased tumor growth, the probiotics helped to improve the anti-tumor effects of the therapy. By altering gut bacteria and boosting certain immune responses, this suggests that probiotics could be a novel approach to enhance cancer treatment, especially for patients undergoing antimicrobial therapy.
Surprisingly, while the antibiotic alone led to increased tumor growth, the probiotics helped to improve the anti-tumor effects of the therapy. By altering gut bacteria and boosting certain immune responses, this suggests that probiotics could be a novel approach to enhance cancer treatment, especially for patients undergoing antimicrobial therapy.
Read More
9
Bifidobacterium longum enhances treatment efficacy
Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials.
High relevance for treatment alternatives
We examined the impact of probiotics on Helicobacter pylori eradication treatment. By analyzing data from 91 randomized controlled trials with nearly 13,700 participants, we found that adding probiotics significantly improved the eradication success rate.
Specifically, a strain called Bifidobacterium longum showed remarkable results, achieving an effectiveness rate of 81%. Beyond increasing effectiveness, probiotics also reduced common side effects such as nausea, diarrhea, and abdominal pain, making treatment more manageable.
Specifically, a strain called Bifidobacterium longum showed remarkable results, achieving an effectiveness rate of 81%. Beyond increasing effectiveness, probiotics also reduced common side effects such as nausea, diarrhea, and abdominal pain, making treatment more manageable.
Read More
9
B. longum enhances liver recovery
Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma.
Significant relevance to cancer recovery
We explored how timely liver function recovery (LFR) impacts long-term survival in hepatocellular carcinoma (HCC) patients and discovered Bifidobacterium longum, which is linked to improved recovery. In our study, we found that transferring fecal microbiota from HCC patients with delayed recovery to mice affected their recovery. Remarkably, giving these mice B. longum sped up their liver repair. In a clinical trial, a probiotic cocktail with B. longum significantly lowered recovery delays and shortened hospital stays for HCC patients, ultimately boosting their one-year survival rates.
Read More
User Reviews
USERS' SCORE
Good
Based on 3 Reviews
8.5
8.8
Improved intestinal health
I am pleasantly surprised. After taking 2 or 3 tablets daily for ten days, I noticed positive changes. My usual morning stool now comes out around 2 pm. Previously, I experienced painful bloating after lunch, but that discomfort has disappeared, and my bowel movements are much smoother. After my mother died of colon cancer, I feared inheriting that issue, so I started this to improve my gut health. I look forward to continuing this and hope it will benefit both my intestinal and skin health over the next three months.
Read More
8.5
Effective against constipation
I had high hopes for this probiotic after experiencing cancer previously. It effectively alleviates my severe constipation, and I noticed positive results within five years, even with just one a day. I will definitely repurchase!
8
Positive response noted
Good effects of lactic acid bacteria. After taking it two hours post-meal, my constipation improved, which is a welcomed relief. I also heard that maintaining bowel health may reduce the recurrence of cancer.
